← Back to all trials
Not Yet Recruiting
NCT05713981
The Impact of Dry Eye Syndrome on Metrics of Low Contrast Vision Before and After Meibomian Gland Expression
Conditions: Meibomian Gland Dysfunction
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: 1
Phase: NA
Enrollment: 40
Sponsor: University of the Incarnate Word
Location: United States
Summary
The study aims to determine the impact of Meibomian Gland Dysfunction (MGD) dry eye on low contrast black/white (luminance) and cone color sensitivity performance and improvement in these functions after in-house non-invasive Meibomian gland (MG) expression.
Eligibility Criteria
Inclusion Criteria:Individuals over the age of 18 yearsHealthy individuals with reported symptoms of dry eye such as burning, stinging, fluctuating vision, inappropriate tearing, and feelings of grittiness particularly with prolonged near workExclusion Criteria:Under the age of 18Individuals currently using prescription eye medications for dry eye / MGD / inflammation / Infections or any other treatments.
Source: ClinicalTrials.gov (NCT05713981). StuddyBuddy aggregates publicly available trial information.
